Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christodoulos Papadopoulos

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|September 8, 2022
A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonistsDimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, et al.
Current Pharmaceutical Design|October 16, 2018
Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial HypercholesterolemiaVasilios Papademetriou, Konstantinos Stavropoulos, Christodoulos Papadopoulos, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical ReviewNikolaos Velidakis, Panagiotis Stachteas, Evangelia Gkougkoudi, et al.
Acta Cardiologica|July 11, 2023
Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella reviewEleftherios Teperikidis, Aristi Boulmpou, Victoria Potoupni, et al.
The American Journal of Cardiology|October 13, 2020
Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection FractionDimitrios Patoulias, Christodoulos Papadopoulos, Maria-Styliani Kalogirou, et al.
The American Journal of Cardiology|October 18, 2020
Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance ImagingDimitrios Patoulias, Alexandra Katsimardou, Maria Toumpourleka, et al.
JACC. Case Reports|June 13, 2025
The "Mushroom Sign": An Interesting Case Report of Extreme Stent MalappositionGeorgios Zormpas, Dimitrios Zioutas, Sotirios Mitsiadis, et al.
Journal of Clinical Medicine|March 17, 2025
Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial)Aristi Boulmpou, Theodoros Moysiadis, Georgios Zormpas, et al.
Current Pharmaceutical Design|August 30, 2021
Hypertension in Pregnancy: Unanswered QuestionsVasilios Papademetriou, Konstantinos Stavropoulos, Dimitrios Patoulias, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|December 5, 2025
When Everything Else Fails: TricValve® in a Dialysis-Dependent Patient with Advanced Right Heart FailureAristi Boulmpou, Alexandros Kallifatidis, Panagiotis Charalampidis, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|September 8, 2022
A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonistsDimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, et al.
Current Pharmaceutical Design|October 16, 2018
Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial HypercholesterolemiaVasilios Papademetriou, Konstantinos Stavropoulos, Christodoulos Papadopoulos, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical ReviewNikolaos Velidakis, Panagiotis Stachteas, Evangelia Gkougkoudi, et al.
Acta Cardiologica|July 11, 2023
Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella reviewEleftherios Teperikidis, Aristi Boulmpou, Victoria Potoupni, et al.
The American Journal of Cardiology|October 13, 2020
Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection FractionDimitrios Patoulias, Christodoulos Papadopoulos, Maria-Styliani Kalogirou, et al.
The American Journal of Cardiology|October 18, 2020
Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance ImagingDimitrios Patoulias, Alexandra Katsimardou, Maria Toumpourleka, et al.
JACC. Case Reports|June 13, 2025
The "Mushroom Sign": An Interesting Case Report of Extreme Stent MalappositionGeorgios Zormpas, Dimitrios Zioutas, Sotirios Mitsiadis, et al.
Journal of Clinical Medicine|March 17, 2025
Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial)Aristi Boulmpou, Theodoros Moysiadis, Georgios Zormpas, et al.
Current Pharmaceutical Design|August 30, 2021
Hypertension in Pregnancy: Unanswered QuestionsVasilios Papademetriou, Konstantinos Stavropoulos, Dimitrios Patoulias, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|December 5, 2025
When Everything Else Fails: TricValve® in a Dialysis-Dependent Patient with Advanced Right Heart FailureAristi Boulmpou, Alexandros Kallifatidis, Panagiotis Charalampidis, et al.
Pageof 13